World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 15 April 2024
Main ID:  NCT02290392
Date of registration: 11/11/2014
Prospective Registration: Yes
Primary sponsor: National Human Genome Research Institute (NHGRI)
Public title: Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0
Scientific title: The Minority Health Genomics and Translational Research BIo-Repository Database (MH-GRID)-2.0
Date of first enrolment: November 11, 2014
Target sample size: 1692
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT02290392
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Amadou Gaye, M.D.
Address: 
Telephone:
Email:
Affiliation:  National Human Genome Research Institute (NHGRI)
Key inclusion & exclusion criteria

- INCLUSION CRITERIA:

- The MH-GRID Project s inclusion criteria included AA age 30-55 years

- Severe controlled HTN or severe resistant HTN.

EXCLUSION CRITERIA:

- Exclusion criteria involved patients with secondary forms of HTN, primary forms of
kidney disease or major co-morbidities (e.g. diabetes, heart failure, end-stage renal
failure, HIV, and liver disease).

- Children <18 were not enrolled in the protocol.



Age minimum: 30 Years
Age maximum: 55 Years
Gender: All
Health Condition(s) or Problem(s) studied
Hypertension
Intervention(s)
Primary Outcome(s)
To complete the original MH-GRID primary outcome analyses by defining the genetic, behavioral , and social-environmental determinants of severe hypertension and other cardio-metabolic disorders in individuals of African ancestry. [Time Frame: one time analysis]
Secondary Outcome(s)
The secondary outcome variables include obesity, coronary heart disease and metabolic disease syndrome. Intervening variables include genetics, behavioral, ancestry, social, biological, and environmental. [Time Frame: one time analysis]
Secondary ID(s)
15-HG-N011
999915011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Heart, Lung, and Blood Institute (NHLBI)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history